Concepedia

Author

André Kahan

Hôpital Cochin

Also Known As

A KAHAN, A Kahan, A. KAHAN, A. Kahan, ANDRE KAHAN, ANDRÉ KAHAN, Alice Kahan, Andre Kahan, André Kahan, Andrè Kahan

398

Publications

14.1K

Citations

67

H-Index

135

Concepts

All Affiliations

Hôpital CochinUniversité Paris CitéAssistance Publique – Hôpitaux de ParisDélégation Paris 5Inserm
AK

About

André Kahan is an author at Hôpital Cochin specializing in medicine, scleroderma, and rheumatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

34

56

3K

2

Public Health

10

10

491

3

Health Sciences

3

3

376

4

Education

1

1

18

5

Engineering

1

1

18

André Kahan

×

164

Publications

11.4K

Citations

62

H-Index

YearCitations

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

É. Hachulla, Virginie Gressin, Patrick Carpentier,

Arthritis & Rheumatism

2005

733

Long‐term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: The study on osteoarthritis progression prevention, a two‐year, randomized, double‐blind, placebo‐controlled trial

André Kahan, Daniel Uebelhart, Florent de Vathaire,

Arthritis & Rheumatism

2009

265

Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis

Yannick Allanore, Christophe Meune, Madelon C Vonk,

Annals of the Rheumatic Diseases

2009

261

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment [published erratum appears in Br J Rheumatol 1998 Oct;37(10):1142]

C J Hawkey, André Kahan, Klaus Steinbrück,

Lara D. Veeken

1998

259

High N‐terminal pro–brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis

Yannick Allanore, Didier Borderie, Jérôme Avouac,

Arthritis & Rheumatism

2007

241

Genome-Wide Scan Identifies TNIP1, PSORS1C1, and RHOB as Novel Risk Loci for Systemic Sclerosis

Yannick Allanore, Mohamad Saad, Philippe Dieudé,

PLoS Genetics

2011

229

Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX- inhibiting Therapies (SELECT) trial in osteoarthritis

J. Dequeker, Christopher J. Hawkey, André Kahan,

Lara D. Veeken

1998

225

Radiological hand involvement in systemic sclerosis

Jérôme Avouac, H. Guérini, J. Wipff,

Annals of the Rheumatic Diseases

2006

211

The three‐year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France

É. Hachulla, Pascal de Groote, Virginie Gressin,

Arthritis & Rheumatism

2009

203

Cardiac involvement in systemic sclerosis assessed by tissue‐doppler echocardiography during routine care: A controlled study of 100 consecutive patients

Christophe Meune, Jérôme Avouac, Karim Wahbi,

Arthritis & Rheumatism

2008

194

Page 1